Quick Answer
TransMedics Group, Inc. reported Long-Term Debt of $58.70 million for fiscal year 2022.
TransMedics Group, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2022 | $58.70M | +66.8% |
| 2021 | $35.20M | +1.6% |
| 2020 | $34.66M | +1.5% |
| 2019 | $34.15M | +1.4% |
| 2018 | $33.67M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| March 31, 2023 | $58.80M | +66.4% | +0.2% |
| December 31, 2022 | $58.70M | +66.8% | +0.3% |
| September 30, 2022 | $58.54M | +67.0% | +65.0% |
| June 30, 2022 | $35.48M | +1.6% | +0.4% |
| March 31, 2022 | $35.33M | +1.6% | +0.4% |
| December 31, 2021 | $35.20M | +1.6% | +0.4% |
| September 30, 2021 | $35.06M | +1.5% | +0.4% |
| June 30, 2021 | $34.92M | +1.5% | +0.4% |
- TransMedics Group, Inc. showed an increase of +66.8% in Long-Term Debt compared to the prior fiscal year.
- Over the 2018–2022 period, TransMedics Group, Inc.’s long-term debt has grown by 74.3% (from $33.67 million to $58.70 million).
- The most recent figure is from TransMedics Group, Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on February 27, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: